These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 38367868)
1. The therapeutic potential of targeting the CHD protein family in cancer. Zhang M; Wu K; Zhang W; Lin X; Cao Q; Zhang L; Chen K Pharmacol Ther; 2024 Apr; 256():108610. PubMed ID: 38367868 [TBL] [Abstract][Full Text] [Related]
2. The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer. Mills AA Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28096241 [TBL] [Abstract][Full Text] [Related]
3. Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease. Alendar A; Berns A Genes Dev; 2021 Nov; 35(21-22):1403-1430. PubMed ID: 34725129 [TBL] [Abstract][Full Text] [Related]
4. CHD proteins: a diverse family with strong ties. Hall JA; Georgel PT Biochem Cell Biol; 2007 Aug; 85(4):463-76. PubMed ID: 17713581 [TBL] [Abstract][Full Text] [Related]
5. Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders. Muhammad T; Pastore SF; Good K; Ausió J; Vincent JB Psychiatr Genet; 2023 Dec; 33(6):213-232. PubMed ID: 37851134 [TBL] [Abstract][Full Text] [Related]
6. Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes. Li W; Mills AA Epigenomics; 2014; 6(4):381-95. PubMed ID: 25333848 [TBL] [Abstract][Full Text] [Related]
7. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity. Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779 [TBL] [Abstract][Full Text] [Related]
8. Different CHD chromatin remodelers are required for expression of distinct gene sets and specific stages during development of Dictyostelium discoideum. Platt JL; Rogers BJ; Rogers KC; Harwood AJ; Kimmel AR Development; 2013 Dec; 140(24):4926-36. PubMed ID: 24301467 [TBL] [Abstract][Full Text] [Related]
9. The Roles of Chromatin Remodeling Proteins in Cancer. Zhang C; Lu J; Zhang P Curr Protein Pept Sci; 2016; 17(5):446-54. PubMed ID: 26796304 [TBL] [Abstract][Full Text] [Related]
10. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update. Banerjee S; Roy S Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813 [TBL] [Abstract][Full Text] [Related]
11. A Chromodomain-Helicase-DNA-Binding Factor Functions in Chromatin Modification and Gene Regulation. Lu Y; Tan F; Zhao Y; Zhou S; Chen X; Hu Y; Zhou DX Plant Physiol; 2020 Jul; 183(3):1035-1046. PubMed ID: 32439720 [TBL] [Abstract][Full Text] [Related]
12. The Chd family of chromatin remodelers. Marfella CG; Imbalzano AN Mutat Res; 2007 May; 618(1-2):30-40. PubMed ID: 17350655 [TBL] [Abstract][Full Text] [Related]
13. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities. Manning BJ; Yusufzai T J Biol Chem; 2017 Jul; 292(28):11927-11936. PubMed ID: 28533432 [TBL] [Abstract][Full Text] [Related]
14. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7. Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742 [TBL] [Abstract][Full Text] [Related]
15. Targeting Chromatin Remodeling for Cancer Therapy. Kaur J; Daoud A; Eblen ST Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757 [TBL] [Abstract][Full Text] [Related]
16. Overarching control of autophagy and DNA damage response by CHD6 revealed by modeling a rare human pathology. Kargapolova Y; Rehimi R; Kayserili H; Brühl J; Sofiadis K; Zirkel A; Palikyras S; Mizi A; Li Y; Yigit G; Hoischen A; Frank S; Russ N; Trautwein J; van Bon B; Gilissen C; Laugsch M; Gusmao EG; Josipovic N; Altmüller J; Nürnberg P; Längst G; Kaiser FJ; Watrin E; Brunner H; Rada-Iglesias A; Kurian L; Wollnik B; Bouazoune K; Papantonis A Nat Commun; 2021 May; 12(1):3014. PubMed ID: 34021162 [TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer. Mulero-Navarro S; Esteller M Epigenetics; 2008; 3(4):210-5. PubMed ID: 18698156 [TBL] [Abstract][Full Text] [Related]
18. PICKLE is a CHD subfamily II ATP-dependent chromatin remodeling factor. Ho KK; Zhang H; Golden BL; Ogas J Biochim Biophys Acta; 2013 Feb; 1829(2):199-210. PubMed ID: 23128324 [TBL] [Abstract][Full Text] [Related]
19. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Lee C; Kim JK J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881 [TBL] [Abstract][Full Text] [Related]
20. Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases. Micucci JA; Sperry ED; Martin DM Stem Cells Dev; 2015 Apr; 24(8):917-26. PubMed ID: 25567374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]